Cargando…
Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660
Autores principales: | Banerjee, K, Balsitis, S, Jamil, T, Jones, C, Dey, A, Flandez, J, Brito, L, Cu, Y, Beard, C, Santra, S, Pal, R, Miller, N, Valiante, NM, Mason, P, Barnett, SW, Otten, GR |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441338/ http://dx.doi.org/10.1186/1742-4690-9-S2-O8 |
Ejemplares similares
-
Live Attenuated Rev-Independent Nef¯SIV Enhances Acquisition of Heterologous SIVsmE660 in Acutely Vaccinated Rhesus Macaques
por: Byrareddy, Siddappa N., et al.
Publicado: (2013) -
Early Potent Protection against Heterologous SIVsmE660 Challenge Following Live Attenuated SIV Vaccination in Mauritian Cynomolgus Macaques
por: Berry, Neil, et al.
Publicado: (2011) -
Characterization in rabbits & nonhuman primates of the neutralizing antibody response elicited by DNA & protein vaccination with SIVmac251 & SIVsmE660
por: Menon, VP, et al.
Publicado: (2012) -
P19-14. Recombinant alphavirus replicon particles as a platform to evaluate immunogenicity of early transmitted clade C virus envelopes
por: Franti, M, et al.
Publicado: (2009) -
Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
por: Banerjee, K, et al.
Publicado: (2012)